We’re making vital connections

Antidote is on a mission to transform the way that sponsors and patients connect in order to accelerate medical research. To learn more, get in touch.

About

We're doing something that matters

At Antidote, we bring together talented people with pharmaceutical, technology, business, and public health backgrounds to achieve an important mission. Along the way, we manage to have some fun, too.

team-pic-Q1 2022 v2

Thoughts from our team

“Since joining the Antidote team in 2021, I’ve found that the values our company stands for aren’t simply written on the website, but weaved throughout our work every single day. The level of collaboration across all of our departments is nothing I can even compare to past experiences. It makes the work we do that much more meaningful and I’m so grateful to be apart of the Antidote team!”
Valerie
“I have always wanted to be part of a team that changes the world, and I think I found that at Antidote. I’ve been working here for more than seven years, and I clearly see how we are shaping the industry. As an engineer at Antidote, I’m faced with new and exciting challenges, which helps me grow in my field.”
Krasimir
“I started working at Antidote 7 years ago. It has really opened up my eyes in regards to the need for clinical trials. It warms my heart to think that I can help someone possibly make their condition better by connecting them with a clinical trial that uses a new medication. It is a great feeling to be part of the new medication approval process so that it can help many others.”
Ronda

Interested in Antidote’s company values and career opportunities?

Learn more

Leadership

Laurent Schockmel

Laurent Schockmel

CEO
Keith Lovell

Keith Lovell

CFO
Joanna Anderson

Joanna Anderson

VP People
Gini Shoyhet

Gini Shoyhet

VP Marketing & Partnerships
Nicole Batiste

Nicole Batiste

VP Commercial Operations
Kulvinder Maingi

Kulvinder Maingi

CTO
Tom Krohn

Tom Krohn

CDO
Dave Mauro

Dave Mauro

CRO

Our Board

David Currie

David Currie, Founder and Director, Codex Capital Partners LinkedIn

Luke Hakes

Luke Hakes, Partner, Octopus Ventures LinkedIn

Keith Lovell

Keith Lovell, CFO, Antidote LinkedIn

Jordan Mayo

Jordan Mayo, CEO, Profile Pensions LinkedIn

Laurent Schockmel

Laurent Schockmel, CEO, Antidote LinkedIn

Prem Tumkosit

Prem Tumkosit, Managing Director, Merck GHI LinkedIn

Connect with Antidote

We’d love to hear from you